Vocabulary Flashcards

1
Q

drug that activates a receptor by binding to that receptor

A

Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • drug that binds to a receptor without activating that receptor
  • Block the action of agonists simply by getting in the way of the agonist, preventing the agonist from binding to the receptor and producing the drug effect
A

Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

present when increasing concentrations of the antagonist progressively inhibit the response to the agonist.

A

Competitive antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

present when, after administration of an antagonist, even high concentrations of agonist cannot completely overcome the antagonism. (either covalent bond or allosteric bound)

A

Non-competitive antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • drug that binds to a receptor but doesn’t cause full drug effect drug that binds to a receptor (usually at the agonist site) where it activates the receptor but not as much as a full agonist.
  • Even at supramaximal doses, this cannot cause the full drug effect.
  • May also have antagonist activity in which case they are also called agonist-antagonists.
  • When administered with a full agonist, it decreases the effect of the full agonist
A

Partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • bind at the same site as the agonist (and likely compete with it), but they produce the opposite effect of the agonist.
  • “turn off ” the constitutive activity of the receptor
A

Inverse agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

decreased response to the same dose of drug

A

Tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • the quantitative study of the absorption, distribution, metabolism, and excretion of injected and inhaled drugs and their metabolites
  • describes what the body does to a drug
A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

the volume that intravenously injected drug initially mixes into.

A

Central volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tissues receiving high arterial flow.

A

Vessel rich group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

a constant amount of drug is eliminated per unit of time.

A

Zero-order processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • amount eliminated will be dependent on the maximum blood/plasma concentration and not of time
  • indicates that the rate of elimination is proportional to the concentration (ie, the higher the concentration, the greater the amount of drug eliminated per unit time.
A

First-order processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the half-time for equilibration between plasma and the site of the drug effect

A

Elimination Half-time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • the time required for a 50% decrease in x;
  • constant regardless of the amount of drug in the body.
  • The concentration of such a drug in the blood will decrease by 50% for every this
A

Elimination Half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • the time for the plasma concentration to decrease by 50% from an infusion that maintains a constant concentration.
A

Context-sensitive half-time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

the amount of blood completely cleared of drug per unit time

A

Clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describes what the drug does to the body

A

Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

the study of how molecules are structured in three dimension

A

Stereochemistry

19
Q

a molecule with a center of 3 dimensional asymmetry

20
Q

pairs of molecules that are mirror images

A

Enantiomerism

21
Q

enantiomers present in equal proportion

22
Q
  • study of genetic factors determining drug response and the use of gene sequencing or expression profile data to tailor therapies specific to an individual patient
  • The response to many drugs varies greatly among patients
A

Pharmacogenetics

23
Q

temporary loss of recall

24
Q

conscious memory

25
# Dee altered level of consciousness – Minimal, Moderate, and Deep
Sedation
26
drug-induced loss of consciousness during which patients are not arousable, even by painful stimulation. The ability to independently maintain ventilatory function is often impaired. Patients often require assistance in maintaining a patent airway, and positive pressure ventilation may be required because of depressed spontaneous ventilation or drug-induced depression of neuromuscular function. Cardiovascular function may be impaired.
General Anesthesia
27
inability to feel pain
Analgesia
28
pain response from typically non-painful stimulation
Allodynia
29
an abnormally increased sensitivity to pain
Hyperalgesia
30
increased sensitivity to subsequent inoffensive stimuli; refers to the increased responsiveness of peripheral neurons responsible for pain transmission to heat, cold, mechanical, or chemical stimulation
Sensitization
31
pain that persists after tissue injury has healed and is *characterized by reduced sensory and nociceptive thresholds* (allodynia and hyperalgesia); Injury of peripheral nerves by trauma, surgery, or diseases (diabetes) frequently results in the development of this
Neuropathic pain
32
pain related to muscles, skeleton.
Somatic pain
33
* pain related to activation of nociceptors in the thorax, abdomen, pelvis. * Diffuse and poorly localized, typically referred to somatic sites (eg muscle and skin), and it is usually associated with stronger emotional and autonomic reactions
Visceral pain
34
pain in the nerve pathway
Neuralgia
35
appearance of progressive decrease in response to a given dose after repetitive administration of a pharmacologically or physiologically active substance.
Tachyphylaxis
36
combination of 2 drugs with summative effects
Additive
37
combination of 2 drugs with greater than summative effects
Synergistic
38
*the ability to produce the intended result *a measure of the intrinsic ability of a drug to produce a given physiologic or clinical effect.
Efficacy
39
the relationship of the dose to the effect
Potency
40
dose of a drug required to *produce a specific desired effect in 50% of individuals* receiving the drug.
Median effective dose (ED50):
41
the dose of a drug required to produce death in 50% of patients (or more often animals)
Median lethal does (LD50):
42
the ratio between the LD50 and the ED50 (LD50/ED50). The larger this is of a drug, the safer the drug is for clinical administration
Therapeutic index
43
* limited to the short-term, typically extending for days to weeks after injury. * provides an important protective mechanism, signaling the individual to protect the injured region from repeated injury, so that tissue healing can ensue. * Under most circumstances, as tissue heals, the acute sensitization in the region surrounding the injury gradually subsides, and sensory thresholds revert to normal. * Acute pain and the accompanying sensitization that accompany any injury do not typically persist after the initial injury has healed.
Acute pain
44
* is persistent pain that persists after all tissue healing appears to be complete and extends beyond the expected period of healing. * In individuals with chronic pain, pain receptors continue to fire, even in the absence of tissue damage. * There may no longer be a physically discernible tissue injury, yet the pain response persists.
Chronic pain